Annual report
6951.TEDINET S100OISG
Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100RS6X (2023-08-30).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥138.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥110.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥117.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥111.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥104.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥14.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥5.2bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥16.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.5bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥7.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.4bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.4bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥16.7bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.6bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.9bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.5bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥12.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥3.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥189.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥146.4bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥136.8bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥122.7bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥114.6bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥103.7bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥95.4bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥85.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥51.0bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥45.1bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥41.6bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥37.4bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥44.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥42.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.5bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.3bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.8bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥22.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥648m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥468m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥246.78 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.51 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.94 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.95 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥93.81 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,684.08 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,055.5 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥933.07 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥860.9 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥773.84 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 45.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.9% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.6% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 17.9% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.0% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.0% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,291 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 3,198 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 3,165 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 3,029 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 3,008 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥117.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥93.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥102.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥93.9bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥89.7bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥11.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥3.0bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥14.4bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.5bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.2bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.4bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.5bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.5bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.6bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥12.1bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥3.6bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥4.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.4bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥159.8bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥121.2bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥113.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥103.0bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥97.3bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥80.7bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥75.2bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥79.0bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥46.0bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥41.9bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥38.7bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥35.4bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥27.7bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥242.8 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.16 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.13 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.89 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.9 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥50 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16.5 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,548.9 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥952.79 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥867.13 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥802 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥731.8 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 49.5% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.0% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.0% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.3% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 19.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.2% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.2% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 51,532,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,857,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,857,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,857,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 97,715,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,092 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 1,950 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 1,920 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 1,907 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 1,912 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥168m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥287m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥53.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥4.9bn |
| Industrial Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Industrial Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥891m |
| Industrial Equipmentreportable segment | employees | at 2022-03-31 | 499 pure |
| Industrial Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥34.0bn |
| Industrial Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥34.0bn |
| Industrial Equipmentreportable segment | segment assets | at 2022-03-31 | ¥31.8bn |
| Industrial Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥13.1bn |
| Medical Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1.0bn |
| Medical Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥207m |
| Medical Equipmentreportable segment | employees | at 2022-03-31 | 316 pure |
| Medical Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥19.3bn |
| Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥19.3bn |
| Medical Equipmentreportable segment | segment assets | at 2022-03-31 | ¥16.3bn |
| Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Scientific And Measurement Instrumentsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| Scientific And Measurement Instrumentsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.7bn |
| Scientific And Measurement Instrumentsreportable segment | employees | at 2022-03-31 | 2179 pure |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥85.1bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥85.1bn |
| Scientific And Measurement Instrumentsreportable segment | segment assets | at 2022-03-31 | ¥87.6bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.8bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥6.7bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥3.8bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥138.4bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥138.4bn |
| —segment total | segment assets | at 2022-03-31 | ¥135.6bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥19.0bn |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥440m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥225m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥26.1bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥4.2bn |
| Industrial Equipmentreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥4.5bn |
| Industrial Equipmentreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥610m |
| Industrial Equipmentreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥24.0bn |
| Industrial Equipmentreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥24.0bn |
| Industrial Equipmentreportable segment | segment assets | at 2021-03-31 | ¥24.6bn |
| Industrial Equipmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥7.3bn |
| Medical Equipmentreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥176m |
| Medical Equipmentreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥155m |
| Medical Equipmentreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥15.9bn |
| Medical Equipmentreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥15.9bn |
| Medical Equipmentreportable segment | segment assets | at 2021-03-31 | ¥16.5bn |
| Medical Equipmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥945m |
| Scientific And Measurement Instrumentsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥2.4bn |
| Scientific And Measurement Instrumentsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2.6bn |
| Scientific And Measurement Instrumentsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥70.6bn |
| Scientific And Measurement Instrumentsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥70.6bn |
| Scientific And Measurement Instrumentsreportable segment | segment assets | at 2021-03-31 | ¥79.2bn |
| Scientific And Measurement Instrumentsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥7.1bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥3.4bn |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥110.4bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥110.4bn |
| —segment total | segment assets | at 2021-03-31 | ¥120.3bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥9.4bn |
| Industrial Equipmentreportable segment | employees | at 2022-03-31 | 357 pure |
| Medical Equipmentreportable segment | employees | at 2022-03-31 | 301 pure |
| Scientific And Measurement Instrumentsreportable segment | employees | at 2022-03-31 | 1288 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,889
| Item | Context | Value | Unit |
|---|---|---|---|
| Disposal of treasury stock | CurrentYearDuration | 38000000 | JPY |
| Increase and decrease due to change in fiscal year end of consolidated subsidiaries | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | － | JPY |
| Increase and decrease due to change in fiscal year end of consolidated subsidiaries | CurrentYearDuration | 42000000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_ValuationDifferenceOnAvailableForSaleSecuritiesMember | -508000000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_DeferredGainsOrLossesOnHedgesMember | -43000000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember | 1316000000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember | 376000000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | 1140000000 | JPY |
| Net changes of items other than shareholders equity | CurrentYearDuration | 1140000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_ValuationDifferenceOnAvailableForSaleSecuritiesMember | -508000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_DeferredGainsOrLossesOnHedgesMember | -43000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember | 1316000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember | 376000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | 1140000000 | JPY |
| Total changes of items during the period | CurrentYearDuration | 34906000000 | JPY |
| Net assets | CurrentYearInstant_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 3605000000 | JPY |
| Net assets | CurrentYearInstant_DeferredGainsOrLossesOnHedgesMember | -69000000 | JPY |
| Net assets | CurrentYearInstant_ForeignCurrencyTranslationAdjustmentMember | -142000000 | JPY |
| Net assets | CurrentYearInstant_RemeasurementsOfDefinedBenefitPlansMember | 187000000 | JPY |
| Net assets | CurrentYearInstant_ValuationAndTranslationAdjustmentsMember | 3581000000 | JPY |
| Net assets | CurrentYearInstant | 85904000000 | JPY |
| Income before income taxes | Prior1YearDuration | 5614000000 | JPY |
| Income before income taxes | CurrentYearDuration | 16651000000 | JPY |
| Depreciation and amortization ope cf | Prior1YearDuration | 3626000000 | JPY |
| Depreciation and amortization ope cf | CurrentYearDuration | 4105000000 | JPY |
| Amortization of goodwill ope cf | Prior1YearDuration | 590000000 | JPY |
| Amortization of goodwill ope cf | CurrentYearDuration | 229000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YearDuration | -0 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | 241000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YearDuration | -111000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYearDuration | -62000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1YearDuration | -17000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | CurrentYearDuration | 6000000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | Prior1YearDuration | 109000000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | CurrentYearDuration | 179000000 | JPY |
| Loss gain on sales and retirement of noncurrent assets ope cf | Prior1YearDuration | -96000000 | JPY |
| Loss gain on sales and retirement of noncurrent assets ope cf | CurrentYearDuration | 35000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YearDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | -394000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YearDuration | 15000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYearDuration | 20000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | -242000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | -193000000 | JPY |
| Subsidy income ope cf | Prior1YearDuration | － | JPY |
| Subsidy income ope cf | CurrentYearDuration | -729000000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | 1017000000 | JPY |
| Impairment loss ope cf | CurrentYearDuration | － | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -189000000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -231000000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 159000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |